Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, parallel controlled study to determine the efficacy and
safety of transcatheter arterial chemoembolization (TACE) on downstaging hepatocellular
carcinoma beyond University of California, San Francisco (UCSF) criteria.